Cefaly for Migraine

Overview
Cefaly is a U.S. Food and Drug Administration (FDA)-cleared medical device for the treatment and prevention of migraine in individuals aged 18 and older. Two versions of the device are available: Cefaly Enhanced and Cefaly Connected. Both devices provide dual treatment modes, one for providing immediate pain relief and one for daily use to reduce migraine frequency.

Cefaly uses neurostimulation, which involves the delivery of mild electrical impulses to calm and desensitize the trigeminal nerve. This process is believed to reduce the nerve's sensitivity to migraine triggers and pain pathways.

How is it used?
Device instructions state that Cefaly is used by placing an adhesive electrode on the forehead. The device attaches magnetically to the electrode, and the user selects one of two treatment modes: In Acute mode, the device is used in a 60-minute session for relief during a migraine attack. In Prevent mode, it is used in daily 20-minute sessions designed to reduce the frequency and intensity of migraine attacks over time.

Cefaly Enhanced is operated manually, with users selecting treatment modes on the device itself. Cefaly Connected offers the same manual operation but also includes Bluetooth compatibility, enabling users to control and monitor treatments through the CeCe Migraine Management App.

Side effects
Common side effects of Cefaly include temporary forehead redness and mild skin irritation at the electrode site. Some users may experience sleepiness during treatment sessions. These effects are generally short-lived and resolve after use.

Rare but serious side effects may include nausea, prolonged headaches, or a reaction to the electrode gel. If these symptoms persist, discontinue use and consult a healthcare provider.

For more information about this treatment, visit:

Cefaly Enhanced User Manual — Cefaly Technology

Cefaly Connected User Manual — Cefaly Technology